title: [ANCA vasculitis: Is it time to change the standard of care for maintenance?].
authors.affiliation: Service de médecine interne, hôpital Cochin, AP-HP, université Paris Descartes, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France. Electronic address: loic.guillevin@aphp.fr.
authors.forename: L
authors.initials: L
authors.lastname: Guillevin
authors.affiliation: Service de médecine interne, hôpital Cochin, AP-HP, université Paris Descartes, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
authors.forename: B
authors.initials: B
authors.lastname: Terrier
mesh_terms: D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000628:therapy*; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000009:adverse effects; D006801:Humans; D060046:Maintenance Chemotherapy / Q000379:methods; D010818:Practice Patterns, Physicians' / Q000639:trends; D057285:Precision Medicine; D000069283:Rituximab / Q000627:therapeutic use; D059039:Standard of Care
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D000069283:Rituximab
keywords: ANCA; Azathioprine; Maintenance therapy; Methotrexate; Méthotrexate; Rituximab; Traitement d’entretien; Vascularites; Vasculitis